BioWorld

Oct. 14, 2002

Advanced Tissue Selling Interest In Dermagraft, Plans Bankruptcy

As part of a restructuring plan that has cost many employees of Advanced Tissue Sciences Inc. their jobs, the company intends to sell its interest in its Dermagraft joint venture to partner Smith & Nephew. (BioWorld Today) Read More

Advisory Panel Wants Broader Oversight Of Study Participants

Why Does Chemotherapy Cause Baldness But Spare Other Healthy Cells? Article Imputes Apoptosis

Biomira Reduces Staff Again To Focus On Cancer Vaccines

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Feb. 6, 2025.

MJFF grant supports Bexorg’s translational biomarker work

BioWorld Science

Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...

REST emerges as biomarker in ALS, knockdown improves ALS symptoms

BioWorld Science

About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...

Serotonin receptor modulators for the treatment of OUD

BioWorld Science

Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...

KLF15 shows potential as marker, target for cholangiocarcinoma

BioWorld Science

Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...